94 documents

  • Emmanuel Deau, Elodie Robin, Raluca Voinea, Nathalie Percina, Grzegorz Satała, et al.. Rational Design, Pharmacomodulation, and Synthesis of Dual 5-Hydroxytryptamine 7 (5-HT 7 )/5-Hydroxytryptamine 2A (5-HT 2A ) Receptor Antagonists and Evaluation by [ 18 F]-PET Imaging in a Primate Brain. Journal of Medicinal Chemistry, 2015, 58 (20), pp.8066-8096. ⟨10.1021/acs.jmedchem.5b00874⟩. ⟨hal-03082898⟩
  • L Cobret, M L de Tauzia, J Ferent, E Traiffort, I Hénaoui, et al.. Targeting the cis-dimerization of LINGO-1 with low MW compounds affects its downstream signalling. British Journal of Clinical Pharmacology, 2015, 172 (3), pp.841-856. ⟨10.1111/bph.12945⟩. ⟨hal-01170735⟩
  • Fanny Duhr, Paul Déléris, F. Raynaud, Martial Séveno, Séverine Morisset-Lopez, et al.. Cdk5 induces constitutive activation of 5-HT6 receptors to promote neurite growth. Nature Chemical Biology, 2014, 10 (7), pp.590-597. ⟨10.1038/nchembio.1547⟩. ⟨hal-01178901⟩
  • Fabienne Godin, Sandrine Villette, Béatrice Vallée, Michel Doudeau, Séverine Morisset-Lopez, et al.. A fraction of neurofibromin interacts with PML bodies in the nucleus of the CCF astrocytoma cell line.. Biochemical and Biophysical Research Communications, 2012, 418 (4), pp.689-94. ⟨10.1016/j.bbrc.2012.01.079⟩. ⟨hal-00721861⟩
  • Séverine Morisset-Lopez, Hélène Bénédetti. Tools for the identification od LINGO-1, LINGO-2, LINGO-3 and LINGO-4, ligands, and uses thereof. France, Patent n° : WO2011121257. BCT. 2011. ⟨hal-02130935⟩
  • M. Picard, S. Morisset, J.F. Cloix, J.C. Bizot, M. Guerin, et al.. Pharmacological, neurochemical, and behavioral profile of JB-788, a new 5-HT1A agonist. Neuroscience, 2010, 169 (3), pp.1337-1346. ⟨10.1016/j.neuroscience.2010.05.040⟩. ⟨hal-02071835⟩
  • Mouhammad Motawaj, Aude Burban, Elisabeth Davenas, Florence Gbahou, Raphaël Faucard, et al.. Le système histaminergique : une cible pour de nouveaux traitements des deficits cognitifs. Thérapie, 2010, 65 (5), pp.415-422. ⟨10.2515/therapie/2010058⟩. ⟨hal-02071208⟩
  • F. Gbahou, E. Davenas, S. Morisset, J.- Arrang. Effects of Betahistine at Histamine H3 Receptors: Mixed Inverse Agonism/Agonism In Vitro and Partial Inverse Agonism In Vivo. Journal of Pharmacology and Experimental Therapeutics, 2010, 334 (3), pp.945-954. ⟨10.1124/jpet.110.168633⟩. ⟨hal-02071192⟩
  • Jacques Pantel, Marie Legendre, Sylvie Nivot, Séverine Morisset, Marie Vie-Luton, et al.. Recessive Isolated Growth Hormone Deficiency and Mutations in the Ghrelin Receptor. Journal of Clinical Endocrinology and Metabolism, 2009, 94 (11), pp.4334-4341. ⟨10.1210/jc.2009-1327⟩. ⟨hal-02081574⟩
  • W. Beghdadi, A. Porcherie, Schneider B.S., S. Morisset, D. Dubayle, et al.. Histamine H3 receptor-mediated signaling protects mice from cerebral malaria.. PLoS ONE, 2009, 4, pp.e6004. ⟨hal-00397938⟩

Documents récupérés de l'archive ouverte HAL logo

ORCID

ResearchID